LK
Laxmi Kant Mundra
About Laxmi Kant Mundra
Data last updated:
Laxmi Kant Mundra is a Director at Parth Formulation Private Limited (since 2005). The companies operate in Chemicals. Parth Formulation Private Limited reported revenue of ₹1.52 Cr (FY 2024). Earlier, Laxmi Kant Mundra was a Director at Mcleod Life Science Private Limited (from 2010).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Parth Formulation Private Limited U24232RJ2003PTC018777 | Director | 08 Dec 2005 | 2003 | ₹1.52 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Mcleod Life Science Private Limited U70200RJ2010PTC032780 | Director | 08 Sep 2010 | 2010 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Laxmi Kant Mundra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Keshav Mundra | 10739191 | Parth Formulation Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Laxmi Kant Mundra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Laxmi Kant Mundra
Laxmi Kant Mundra currently holds 1 directorship: Parth Formulation Private Limited (Director, since 08 Dec 2005, revenue ₹1.52 Cr (FY 2024)).
Laxmi Kant Mundra was first appointed on 08 Dec 2005 as Director at Parth Formulation Private Limited. The most recent appointment on record is 08 Sep 2010 at Mcleod Life Science Private Limited.
Laxmi Kant Mundra held 1 earlier board appointment: Mcleod Life Science Private Limited (Director, from 08 Sep 2010).
The current boards of Laxmi Kant Mundra's companies include Keshav Mundra (Parth Formulation Private Limited).